drugset / Trial / NCT00169416

Evaluation Of Valaciclovir In Patients With Chickenpox

NCT00169416

Phase 3 Completed 43 enrolled GlaxoSmithKline
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study will assess the safety and efficacy, and the pharmacokinetics of aciclovir and valaciclovir in children with chickenpox following oral administration of valaciclovir, for the purpose of seeking approval of valaciclovir HCl for the treatment of chickenpox.

Timeline

Start
2005-03
Primary completion
2005-08
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Valaciclovir Unknown Oral

Indications